Home Newsfeeds Wolfe Research Maintains Underperform on DocuSign, Raises Price Target to $53

Wolfe Research Maintains Underperform on DocuSign, Raises Price Target to $53

Wolfe Research analyst Alex Zukin maintains DocuSign (NASDAQ:DOCU) with a Underperform and raises the price target from $50 to $53.

byBenzinga Newsdesk

September 12, 2022

1 minute read

Wolfe Research analyst Alex Zukin maintains DocuSign (NASDAQ:DOCU) with a Underperform and raises the price target from $50 to $53.

Volatility In Markets Eases Following Jobless Claims Report

By Lisa Levin

December 9, 6:52 AM

US stocks closed higher on Thursday, with the S&P 500 snapping a five-session losing streak as investors digested weekly jobless claims data. US initial jobless claims rose by 4,000 to 230,000 in the week ending December 3, matching market estimates.

AAPL

Barclays Maintains Overweight on Healthpeak Properties, Lowers Price Target to $36

By Benzinga Newsdesk

September 9, 7:00 AM

Barclays analyst Steve Valiquette maintains Healthpeak Properties (NYSE:PEAK) with a Overweight and lowers the price target from $38 to $36.

PEAK

Japan Airlines Faces Over $100M Loss After Tragic Plane Collision At Haneda Airport

By Benzinga Neuro

January 4, 4:32 AM

Japan Airlines estimates a loss exceeding $100 million following a collision at Tokyo's Haneda airport. The financial impact will be covered by insurance, primarily under a $130 million policy from AIG for the affected Airbus.

AIG